Cargando…

The deubiquitinase OTUB1 fosters papillary thyroid carcinoma growth through EYA1 stabilization

Deubiquitinating enzyme OTU domain‐containing ubiquitin aldehyde‐binding proteins 1 (OTUB1) has been shown to have an essential role in multiple carcinomas. However, the function of OTUB1 in papillary thyroid cancer (PTC) and the underlying mechanisms regulating PTC cells proliferation remain poorly...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Peiyi, Chao, Qing, Mao, Jiuang, Liu, Yue, Fang, Jiayu, Xie, Jing, Zhen, Jing, Ding, Yongqi, Fu, Bidong, Ke, Yun, Huang, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642681/
https://www.ncbi.nlm.nih.gov/pubmed/34773364
http://dx.doi.org/10.1111/jcmm.17020
_version_ 1784609718061236224
author Xie, Peiyi
Chao, Qing
Mao, Jiuang
Liu, Yue
Fang, Jiayu
Xie, Jing
Zhen, Jing
Ding, Yongqi
Fu, Bidong
Ke, Yun
Huang, Da
author_facet Xie, Peiyi
Chao, Qing
Mao, Jiuang
Liu, Yue
Fang, Jiayu
Xie, Jing
Zhen, Jing
Ding, Yongqi
Fu, Bidong
Ke, Yun
Huang, Da
author_sort Xie, Peiyi
collection PubMed
description Deubiquitinating enzyme OTU domain‐containing ubiquitin aldehyde‐binding proteins 1 (OTUB1) has been shown to have an essential role in multiple carcinomas. However, the function of OTUB1 in papillary thyroid cancer (PTC) and the underlying mechanisms regulating PTC cells proliferation remain poorly understood. In this study, OTUB1 was significantly upregulated in papillary thyroid carcinoma tissues and cells. Through in vitro and in vivo experiments, knockdown of OTUB1 suppressed PTC cells growth whereas OTUB1 overexpression enhanced the proliferation ability of PTC cells. Moreover, the eyes absent homologue 1 (EYA1) was recognized as a potential target of OTUB1 through mass spectrometry analysis, and we further verified that EYA1 protein level was positively correlated with OTUB1 expression in PTC cells and clinical samples. Mechanistically, OTUB1 could interact with EYA1 directly and deubiquitinate EYA1 to stabilize it. At last, EYA1 was found to play an essential role in OTUB1‐derived PTC cells growth. Overall, our investigation reveals that OTUB1 is a previously unrecognized oncogenic factor in PTC cells proliferation and suggests that OTUB1 might be a novel therapeutic target in PTC.
format Online
Article
Text
id pubmed-8642681
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86426812021-12-15 The deubiquitinase OTUB1 fosters papillary thyroid carcinoma growth through EYA1 stabilization Xie, Peiyi Chao, Qing Mao, Jiuang Liu, Yue Fang, Jiayu Xie, Jing Zhen, Jing Ding, Yongqi Fu, Bidong Ke, Yun Huang, Da J Cell Mol Med Original Articles Deubiquitinating enzyme OTU domain‐containing ubiquitin aldehyde‐binding proteins 1 (OTUB1) has been shown to have an essential role in multiple carcinomas. However, the function of OTUB1 in papillary thyroid cancer (PTC) and the underlying mechanisms regulating PTC cells proliferation remain poorly understood. In this study, OTUB1 was significantly upregulated in papillary thyroid carcinoma tissues and cells. Through in vitro and in vivo experiments, knockdown of OTUB1 suppressed PTC cells growth whereas OTUB1 overexpression enhanced the proliferation ability of PTC cells. Moreover, the eyes absent homologue 1 (EYA1) was recognized as a potential target of OTUB1 through mass spectrometry analysis, and we further verified that EYA1 protein level was positively correlated with OTUB1 expression in PTC cells and clinical samples. Mechanistically, OTUB1 could interact with EYA1 directly and deubiquitinate EYA1 to stabilize it. At last, EYA1 was found to play an essential role in OTUB1‐derived PTC cells growth. Overall, our investigation reveals that OTUB1 is a previously unrecognized oncogenic factor in PTC cells proliferation and suggests that OTUB1 might be a novel therapeutic target in PTC. John Wiley and Sons Inc. 2021-11-12 2021-12 /pmc/articles/PMC8642681/ /pubmed/34773364 http://dx.doi.org/10.1111/jcmm.17020 Text en © 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Xie, Peiyi
Chao, Qing
Mao, Jiuang
Liu, Yue
Fang, Jiayu
Xie, Jing
Zhen, Jing
Ding, Yongqi
Fu, Bidong
Ke, Yun
Huang, Da
The deubiquitinase OTUB1 fosters papillary thyroid carcinoma growth through EYA1 stabilization
title The deubiquitinase OTUB1 fosters papillary thyroid carcinoma growth through EYA1 stabilization
title_full The deubiquitinase OTUB1 fosters papillary thyroid carcinoma growth through EYA1 stabilization
title_fullStr The deubiquitinase OTUB1 fosters papillary thyroid carcinoma growth through EYA1 stabilization
title_full_unstemmed The deubiquitinase OTUB1 fosters papillary thyroid carcinoma growth through EYA1 stabilization
title_short The deubiquitinase OTUB1 fosters papillary thyroid carcinoma growth through EYA1 stabilization
title_sort deubiquitinase otub1 fosters papillary thyroid carcinoma growth through eya1 stabilization
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642681/
https://www.ncbi.nlm.nih.gov/pubmed/34773364
http://dx.doi.org/10.1111/jcmm.17020
work_keys_str_mv AT xiepeiyi thedeubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT chaoqing thedeubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT maojiuang thedeubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT liuyue thedeubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT fangjiayu thedeubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT xiejing thedeubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT zhenjing thedeubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT dingyongqi thedeubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT fubidong thedeubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT keyun thedeubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT huangda thedeubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT xiepeiyi deubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT chaoqing deubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT maojiuang deubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT liuyue deubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT fangjiayu deubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT xiejing deubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT zhenjing deubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT dingyongqi deubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT fubidong deubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT keyun deubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization
AT huangda deubiquitinaseotub1fosterspapillarythyroidcarcinomagrowththrougheya1stabilization